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A B S T R A C T
A standardized 5-level EuroQol 5-dimensional questionnaire (EQ-5D-
5L) valuation protocol was first used in national studies in the period
2012 to 2013. A set of problems encountered in this initial wave of
valuation studies led to the subsequent refinement of the valuation
protocol. To clarify lessons learned and how the protocol was
updated when moving from version 1.0 to the current version 2.1 and
2.0, this article will (1) present the challenges faced in EQ-5D-5L
valuation since 2012 and how these were resolved and (2) describe
in depth a set of new challenges that have become central in
currently ongoing research on how EQ-5D-5L health states should be
valued and modeled.
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Introduction
Experience accumulated during the valuation of the 3-level
EuroQol 5-dimensional questionnaire (EQ-5D-3L), the original
version of the EQ-5D, combined with the added complexities of
the 5-level EQ-5D (EQ-5D-5L), led to the realization that there was
a requirement for a new and standardized approach to valuation.
Variation between protocols used to value the EQ-5D-3L has
provided useful information about successful practices in health
state valuation, but has hampered comparability of value sets.
The introduction of the EQ-5D-5L1 was an opportunity to take
advantage of these experiences and introduce a standardized
valuation protocol, supporting best practices and promoting
comparability of valuation studies.2 This formed the backdrop to
systematic experimentation with valuation methods in the years
around the introduction of the EQ-5D-5L and to subsequent
decisions about the EQ-5D-5L valuation protocol. This
protocol proved a major advance in that it was embedded in
software. Continued use of time trade-off (TTO) preserved
consistency with EQ-5D-3L value sets, and the discrete choices
provided a convenient way to collect additional information about
people’s values for health and to exploit opportunities for hybrid
modeling.
A description of version 1.0 of the EQ-5D-5L valuation protocol
is provided by Oppe et al.3,4 The protocol includes composite TTO
(cTTO) and a discrete choice experiment (DCE). cTTO is a modified
version of the conventional TTO variant that was used in the
seminal Measurement and Valuation of Health study5 and most
subsequent EQ-5D-3L valuation studies. For the evaluation of
health states considered to be better than dead, cTTO offers re-
spondents the conventional task comprising a series of adaptive
choices between x years in full health and 10 years in the disease
state. In an iterative procedure, x is varied to identify the re-
spondent’s point of indifference where the health state value is
given by x/10. When a respondent considers a health state to be
worse than dead, lead-time TTO is used. Respondents are then
offered a series of choices between x years in full health and a
fixed life of 10 years in full health followed by 10 years in the target
* Address correspondence to: Elly Stolk, EuroQol Research Foundation, Marten Meesweg 107, 3068AV Rotterdam, The Netherlands.
E-mail: stolk@euroqol.org
1098-3015 - see front matter Copyright © 2019, ISPOReThe Professional Society for Health Economics and Outcomes Research. Published
by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
https://doi.org/10.1016/j.jval.2018.05.010
Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.elsevier .com/locate / jva l
V A L U E I N H E A L T H 2 2 ( 2 0 1 9 ) 2 3 e3 0
state. As before, x is varied until indifference is reached, and the
health state is given by (x  10)/10.6,7
Before the cTTO task, respondents receive a cTTO warm-up
task featuring the health state “being in a wheelchair.” In-
terviewers are instructed to use this example to explain the cTTO
task and show the range of possible answers (ie, better and worse
than dead). Next, respondents receive 10 real cTTO tasks and 7
choice sets from a DCE. The DCE task requires respondents to
compare 2 health states and indicate which health state is better.
The protocol enables analysts to implement hybrid models that
draw on both types of data when generating their value sets,
following recent literature.8e11 The EQ-5D-5L valuation protocol
was introduced with software for computer-assisted personal
interviews, named the EuroQol Valuation Technique (EQ-VT), and
interviewer instruction manuals.
The first use of the EQ-5D-5L valuation protocol (also referred to
as the EQ-VT protocol) in national studies was in the period 2012 to
2013. A set of problems encountered in the cTTO data of this first
wave of valuation studies led to the subsequent refinement of the
valuation protocol. To clarify lessons learned and to show how the
protocol was updated accordingly, this article will (1) present the
challenges faced in EQ-5D-5L valuation since 2012 and how these
have been addressed and (2) describe a set of new challenges that
have become central in ongoing research with respect to how EQ-
5D-5L health states could be valued and modeled.
Issues With cTTO Data
After the first tranche of EQ-5D-5L valuation studies, which were
conducted in England, the Netherlands, China, Canada, and
Spain, concerns were raised over observations of high rates of
inconsistent responses, clustering of values, low values for mild
states, and few worse than dead responses.12e14 To define the
problem, the valuation data have been analyzed in depth. This
was made possible because the EQ-VT software captures the
entire path that is followed to reach a value and the time stamps
between mouse clicks. Exploiting the richness of these data,
Ramos-Go~ni et al15 found that some interviewers systematically
omitted explanation of the lead-time part of the cTTO task and
elicited no worse than dead values. Furthermore, in some
interviews, a very short time was spent on explaining the cTTO
task and in obtaining a single cTTO value, which could indicate
that respondents minimized effort and expedited the cTTO tasks
by reducing the number of iterations. Because the iterative
procedure requires a different number of steps to reach specific
values (Fig. 1), lack of effortmay partially account for the relatively
low values for mild states (it takes more steps to reach high
values) and clustering of values (a limited number of values can be
attained when a cTTO task is completed with few iterations).
Occurrence of these issues was found to vary across interviewers,
suggesting that interviewer behavior affected the tendency for
respondents to use such shortcuts.
When respondents make choices that result in quick task
completion, this is indicative of respondent behavior that complies
with the requirements of the task, but may still be detrimental to
the precision of the answers that are obtained,15 a general
phenomenon referred to as satisficing.16 Indirectly, this may also
account for the large number of inconsistent valuations.
Although one would expect that the worst state described by the
EQ-5D-5L descriptive system would also receive the lowest value,
roughly 20% of respondents gave at least 1 health state a lower
value.17 An inconsistency could itself be assigned to different
causes, such as task complexity, random error, or learning effects,
but it could also reflect inadequate efforts from respondents who
did not feel compelled to expend resources on providing optimal
answers.
The findings seem to reflect low levels of task engagement on
the part of respondents or interviewers, with detrimental effects
on the quality of the data. Herein we describe how this shaped our
research in subsequent years, when we considered implications
for the EQ-VT protocol and for data handling.
Updated Protocol for Implementing the cTTO Task
(Version 1.1)
Table 1 presents how the protocol evolved over the years, result-
ing in the current version 2.1 that is presented in Table 2. The
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Fig. 1 – Routing implementation in the cTTO task. The left
y-axis represents the bid in life A (number of years y in full
health) that is compared with 10 y in the disease state h
(better than dead) or 10 y in the disease state preceded by
10 y in full health (worse than dead). The right y-axis
reflects the value of h that is obtained when the offered bid
leads to an indifference statement. The arrows indicate
how y is raised or lowered if a respondent selects A (red
arrow) or B (blue arrow) to the bid previously offered. cTTO
indicates composite time trade-off. The green arrow points
to the opening bid.
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identifier conveys the type of change between versions: the first
position is changed for introduction of a significant task element,
whereas the decimal changes with the way of implementing the
tasks. In version 1.1 of the EQ-VT protocol, we implemented
several suggestions aimed at capturing better data from the
existing valuation tasks. We added 3 practice states following the
wheelchair example to familiarize respondents with the cTTO
task and with the severity range of health state descriptions. In
addition, confirmatory pop-ups were implemented to validate
answers before storing them. Furthermore, we started to monitor
interviewer performance during data collection to enable timely
intervention if problems were detected. We introduced a quality
control (QC) procedure to review protocol compliance and inter-
viewer effects while the study was ongoing.15 Also, the QC report
flagged up interviews as being of potentially poor quality when
any 1 of the following 4 criteria was met.
1. no explanation of the worse than dead task (lead time) in the
wheelchair example;
2. too short time period spent on the wheelchair example (<3
minutes);
3. clear inconsistency in the cTTO ratings (55555 not the lowest
and at least 0.5 higher than the state with the lowest value);
and
4. 10 cTTO tasks completed in less than 5 minutes.
Initial QC reports were used to evaluate whether interviewers
met minimum quality requirements. If the rate of flagged in-
terviews of an interviewer was 40% or more in the first 10 in-
terviews, then those interviewswere considered ineligible and the
interviewer would be retrained. After another set of 10 interviews,
interviewer performance was evaluated again to decide whether
Table 1 – Overview of valuation studies done using EQ-VT
Valuation
study
EQ-VT elements Extra elements tested in
2013 to inform decisions
about EQ-VT version 2.0EQ-VT v 1.0 EQ-VT v 1.1 EQ-VT v 2.0 EQ-VT v 2.1
Self-
reported
health
Background
questions
cTTO DCE Practice
states
QC
monitoring
FB
Module
Dynamic
question after
wheelchair
example
Better than
dead/worse
than dead
split
Ranking
task
Routing
and
Iteration
Comparator
full
health
Canada ✓ ✓ ✓ ✓
China ✓ ✓ ✓ ✓
England ✓ ✓ ✓ ✓
Netherlands ✓ ✓ ✓ ✓
Spain ✓ ✓ ✓ ✓
Japan ✓ ✓ ✓ ✓ ✓ ✓ ✓
South Korea ✓ ✓ ✓ ✓ ✓ ✓
Thailand ✓ ✓ ✓ ✓ ✓ ✓
Uruguay ✓ ✓ ✓ ✓ ✓ ✓
Australia ✓ ✓ ✓ ✓ ✓ ✓ ✓
Germany ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Hong Kong ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Indonesia ✓ ✓ ✓ ✓ ✓ ✓ ✓
Ireland ✓ ✓ ✓ ✓ ✓ ✓ ✓
Malaysia ✓ ✓ ✓ ✓ ✓ ✓ ✓
Poland ✓ ✓ ✓ ✓ ✓ ✓ ✓
Portugal ✓ ✓ ✓ ✓ ✓ ✓ ✓
Singapore ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Taiwan ✓ ✓ ✓ ✓ ✓ ✓ ✓
Ethiopia ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
France ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Philippines ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Unites States ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Vietnam ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Methodological studies done in 2013 to inform decisions about EQ-VT v 2.0
The Netherlands ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Spain ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
England ✓ ✓ ✓ ✓ ✓ ✓ ✓
Norway ✓ ✓ ✓ 7 ✓ ✓ ✓ ✓
Note. The check mark shows that an element was included; the cross mark indicates that an element of the protocol version used in the study
was dropped.
cTTO indicates composite time trade-off; DCE, discrete choice experiment; EQ-VT, EuroQol Valuation Technology; QC, quality control.
Table 2 – Elements of the EQ-5D-5L valuation protocol 2.0.
Start interview
1. General welcome
2. Introduction
 Self-reported health on the EQ-5D-5L descriptive system
 Self-reported health on the EQ-VAS
 Background questions
3. cTTO
 Instructions and example of cTTO task, 3 practice states
 cTTO valuation of 10 EQ-5D-5L states
 cTTO debriefing/structured feedback
 cTTO feedback module
4. Discrete choice
 Instructions of discrete choice task
 Discrete choice valuation of 7 pairs of EQ-5D-5L states
 Discrete choice debriefing/structured feedback
5. General thank you and goodbye
End interview
Accompanying: a quality control process
cTTO indicates composite time trade-off; EQ-5D-5L, 5-level EuroQol
5-dimensional questionnaire; EQ-VAS, EuroQol visual analogue
scale.
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the interviewer could continue or should be discharged, with
removal of that interviewer's data as a consequence. A lenient
threshold value of 40% was used because a good interview could
not be identified unambiguously (flagged interviews could hold
genuine responses), and to allow interviewers to grow into their
roles when they built up experience. Later, QC reports allowed the
team to continuously reflect on interviewers’ performance and to
discuss potential improvements. The QC process was imple-
mented with the recommendation that each interviewer should
contribute about 100 interviews to allow the establishment of
effective feedback loops.
Although all new requirements increase study cost and may
lead to removal of data, the effectiveness of the process is un-
disputed. Interviewer effects, clustering, and inconsistencies were
dramatically reduced in studies that adhered to the updated
protocol.15
EQ-VT Version 2.0: Introduction of the Feedback
Module
Several other suggestions for remedying data issues were pre-
sented in amodified cTTO task, each connecting different possible
causes for data issues with strategies for their mitigation. A
research program was carried out to test the proposed cTTO task
modifications (included in Table 1) and to assist in informing an
update of the valuation protocol to version 2.0. Teams from Spain,
Japan, the Netherlands, Hong Kong, Norway, Singapore, Germany,
and England were involved in the research program, each allo-
cating participants to a control group that received version 1.1 of
the protocol or to an experimental group that received a modified
protocol.17 This work has resulted in the inclusion of a feedback
module in version 2.0 of the EQ-VT protocol.
The feedback module (Fig. 2) shows respondents what rank
ordering of health states would be inferred from their cTTO re-
sponses. The health state with the highest value is presented at
the top, the lowest at the bottom, and ties side by side. The color of
the box containing a single health state indicates whether that
particular state was considered better (light blue) or worse than
dead (dark blue). Respondents can indicate disagreement with the
implied rank ordering by clicking on the offending health state(s).
No attempt is made to derive new cTTO values. Shah et al17 re-
ported that 1 in 3 respondents reconsidered 1 or more of their
initial responses. This in turn lowered the number of
inconsistencies.
The research program provided no support for the other
modifications tested: separation of the better andworse than dead
task in cTTO, reintroduction of a ranking task for warm-up
Fig. 2 – Example of feedback module in EQ-VT. EQ-VT indicates EuroQol Valuation Technology.
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purposes, relabeling the comparator state in cTTO, and the use of
a different iteration procedure. These modifications had limited
effects on the data, which could reflect diminished scope for
further improvements in cTTO after implementing QC. cTTO,
combined with the QC process outlined earlier, thus appears to
offer researchers a solid basis for constructing their EQ-5D-5L
value function.17
Currently, we are at version 2.1 of the software. This new
version was released in order to promote compatibility of the
software with interviewer instructions. In the normal flow of a
cTTO task, a better than dead or a worse than dead response is
obtained, but interviewers are supposed to show both parts of the
evaluation space using the wheelchair example. This was easy to
forget and difficult to do. After completing the cTTO task for the
wheelchair example, we now include a dynamic question:
Depending on the respondent’s response for the wheelchair, he is
asked to imagine a health state that is much better or much worse
in order to move to the other part of the evaluation space.
Discrete Choice Experiment
In the EQ-VT protocol, the cTTO task has been accompanied by a
DCE task to collect additional information about health state
values. The DCE task comprises pairwise comparisons of 2 EQ-5D-
5L health states and produces by itself no knowledge of how the
derived values relate to the full health (1) to death (0) scale. Thus,
DCE values are derived on a latent scale and are not suited to
replace the cTTO task as a basis for value set generation. Never-
theless, assuming that an individual’s cTTO and DCE responses
both reflect the same underlying preferences for health, and that
DCE- and cTTO-based value functions are the same up to a linear
transformation (bTTO ¼ q bDCE), it may be considered appropriate
to complement cTTO datawith DCE data. This enables a search for
a common set of parameter values using a hybrid model that
maximizes the likelihood of all observations collected in the cTTO
and DCE tasks.18,19
In the Netherlands, Canada, South Korea, Uruguay, and
China, value algorithms were developed on the basis of only
cTTO data,13,20e23 whereas in Spain and England the hybrid
model was adopted.12,14,24 The decisions were often based on
considerations specific to the local context. For example, lack of
software and of documentation initially constituted barriers to
implementation of the hybrid model, and properties of the local
data made some teams push to use a hybrid model while others
chose not to do so.
Theoretically, much depends on the interpretation of possible
differences between cTTO- and DCE-derived values. The two
methods tended to lead to agreement on the utility loss associated
with each severity level,13,24 but perfect agreement should not be
expected. The approaches derive values using different types of
tasks, matching, or choice, and on the basis of different mea-
surement models; in cTTO, all health states are valued against
time, whereas in DCE values are derived on the basis of how
dimension severity levels are traded off against each other. Hence,
there can be concerns with the commensurability of the methods
or the axioms that underpin them. Nevertheless, if one assumes
that both valuation methods capture important aspects of pref-
erences for health and that neither method does so perfectly,
these concerns could be alleviated. Under these assumptions,
hybrid models using cTTO and DCE data are superior in the sense
that they make use of all the available data.10 The inclusion of
more data also can increase the power of the model and result in
more precise parameter estimates.
By enabling hybrid models, DCE data serve an important pur-
pose in the EQ-VT protocol. The DCE data generated have served
this purpose well, although some aspects of the experimental
design may be enhanced. The DCE includes 196 pairs that have
been selected using a Bayesian efficient design algorithm that re-
quires priors for the model’s parameters, with additional hand-
picked pairs comparing 2 mild states.3,25 When modeling the data,
violations of logical orderings of the dimension severity levels were
observed in several countries, particularly pertaining to severity
levels 2 and 3. This distinct problem may be resolved with an up-
date of the design (eg, based on better priors).26Nevertheless, work
on this has been postponed because we have been contemplating a
bigger update of the DCE task, as described in a later section.
Analytical Advances
Although key features of the raw cTTO data have been analyzed
in recent years, researchers have also come to investigate what
these findings imply formodeling of the data. EQ-5D-3L TTO data
were often modeled using simple linear regression. Modeling
approaches of EQ-5D-5L cTTO data are new in that they
commonly account for censoring, heteroskedasticity, trunca-
tion, and/or preference heterogeneity.13,14,24,27 The modeling
advances were driven by considerations obtained from carefully
investigating aspects of the cTTO task and the data it provided,
and by matching these to the assumptions underlying the
regression models. These considerations can be categorized into
3 groups related to (1) mechanics of the cTTO task itself, (2) in-
dividual respondent behavior, and (3) characteristics of the
complete cTTO data set, as presented in Table 3. Even when
improved QC significantly curtails the range of issues that occur
in cTTO data, the issues described are multicausal and will likely
keep recurring, but at a reduced level. The new modeling ap-
proaches thus appear to be generally applicable and to represent
best practice.
An obvious reason to adopt a framework for censored data is
that cTTO data are left-censored at 1, but it is innovative that we
also consider the presence of other types of censoring. Table 3
presents several factors contributing to the view that cTTO re-
sponses can have low levels of accuracy and hence may be better
construed as indicating ranges of values within which the point of
indifference is likely to reside, rather than discrete indifference
points. For example, left-censoring may not be limited to the
bottom value of the scale but could also occur at 0 for people who
were not properly introduced to the worse than dead task. Sat-
isficing can occur if people complete the task half-heartedly or
provide crude responses because their preferences are not well
defined. Then, the quality of the data is downgraded and values
are potentially biased; for example, values for mild states can be
downward-biased because it requires many moves in the cTTO
task to reach high values (see Fig. 1). Frameworks for censored
data have the potential to mitigate such bias and are increasingly
used.14,24,27
A further innovation was the introduction of models that
accommodate heteroskedasticity and non-normality.14,21,27e29 In
health state valuation, variability increases with severity; there is
little disagreement that mild health states are good, but opinions
diverge about how bad moderate and severe states really are (ie,
heteroskedasticity of error terms).30 A cause for non-normality of
the error terms is that cTTO values have a maximum of 1, so that
the value range and error distributions are truncated. When
relatively mild health states are valued, many values at 1 or close
to 1 will be obtained, resulting in a skewed error distribution.
Outliers, if not handled properly, can result in estimates that are
too low, especially for mild states. For this reason, the Uruguayan
EQ-5D-5L tariff was produced using robust regression,20 but
models for censored data can also accommodate heteroskedastic
data. Models for censored data can address several considerations
simultaneously, which explains their growing popularity in
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handling EQ-VT valuation data, as illustrated by some of the latest
articles on EQ-5D-5L value sets.14,27e29
Another way of dealing with heteroskedastic data considers
that it might result from the presence of population subgroups
with different preferences. In particular, the distinction between
people who consider all health states to be better than dead and
people who consider some health states to be worse than dead
causes variance in error terms to increase with severity. Values
obtained from respondents within a subgroup may be similar, but
across subgroups the values can be very different. This recogni-
tion motivated researchers from England to analyze cTTO data
using a latent class model.12,24 Their model assumed that all re-
spondents assigned relative weights to the dimension severity
levels in a similar way, but differed in their views about the po-
sition of dead, and hence their value functions had different
slopes. A latent class model was used to identify subgroups and to
estimate a parameter for the slope in each group (n¼ 3 in England)
and the probability of respondents being in each group. A popu-
lation value set was derived by computing the weighted average
slope using these 6 numbers.
A 5-Year View of EQ-5D-5L Valuation
Although the advances in collecting, interpreting, and analyzing
cTTO health state valuation data have boosted confidence that
teams can successfully produce a valid EQ-5D-5L tariff, the EQ-VT
protocol development may not end at version 2.1. Currently, we
are looking at the possibilities of promoting the feasibility of
valuation studies in a wider context. Interest in health state
valuation studies appears to be increasing, including from small
countries with fewer resources. Arguably, reliance on the cTTO
task as the principal valuation method is a drawback of the cur-
rent protocol, because cTTO is costly and inherently difficult to
implement by investigators who have little experience with
health valuation. This motivated research into the potentialities
of taking more advantage of DCE.
One approach that aimed at deriving greater benefits from
DCE involves further exploitation of the hybrid model. Rowen
et al11 indicated that for the application of a hybrid model on
DCE and cTTO data, it is not necessary to have a high number
of health states in the cTTO task. Slimming down the cTTO
part of EQ-VT has obvious benefits, albeit restricted because
face-to-face interviews will still be required and the learning
curve of cTTO is not avoided. Alternatively, we have consid-
ered the scope for DCE as a primary health state valuation
method. Although the current DCE task derives values on a
latent scale, a variant of this DCE task could include the
duration of a health state as an extra attribute. This would
allow health state values to be defined as the product of the
quantity and quality of life, with the derived values anchored
at full health and dead.31 An advantage of the “DCE duration”
approach is that it derives values from the same conceptual
model as cTTO, but from a task that avoids the complex iter-
ative procedure.31e33 In terms of benefits, exploiting the hybrid
model could yield results faster, whereas DCE duration might
achieve greater benefits.
Although the promises of DCE duration were widely recog-
nized when the EQ-VT protocol was developed, the method has
not yet been implemented as a possible substitute for cTTO
because of concerns with respect to the low values that were
obtained in some initial applications.31,34,35 We considered that
the discrepancies might be, at least partially, explained by dif-
ferences between the 2 approaches in anchoring at dead. Because
cTTO requires observed values, this method includes a task to
assess the strength of preferences of health states that are clas-
sified as worse than dead (ie, lead-time TTO). In contrast, the way
in which the stimuli in the DCE duration task are shown implies
that choices never indicate directly whether a health state has a
worse than dead value. In DCE, extrapolation is required and this
Table 3 – Overview of phenomena that characterize cTTO data and how they can be modeled.
Phenomenon Cause Consequence Possible solution
cTTO task mechanics Censoring of values below 1 For observations at 1 the true
value equals 1 or a lower value
Tobit or interval regression
Left-skewed value distributions at
values close to 1
Models that assume normally
distributed errors can produce
biased estimates
Tobit or interval regression
The smallest tradable unit (in EQ-
VT 6 mo) limits precision of
assessed values
True values equal observed values
±0.025
Interval regression
Individual respondent
behavior
Satisficing: no effort from the
participants to precisely express
their values
Routing biases observed values Interval regression
Respondents do not have well-
defined preferences
Routing biases observed values Interval regression
Time preferences make an
individual’s values cluster at the
top or bottom of the scale*
No discriminative ability within
cluster
Tobit or interval regression
Characteristics of the
complete cTTO
data set
The SD around observed values
increases with worsening quality
of life
Models that assume identical
errors produce biased estimates
Heteroskedastic models
Some people consider all health
states to be better than dead;
others have worse than dead
preferences
Values of different subgroups may
require different treatment (Feng
et al24)
Latent class models
cTTO indicates composite time trade-off; EQ-VT, EuroQol Valuation Technique.
* As discussed by Boye et al44 and by Van der Pol and Shiell.45
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comes with extra uncertainty and has a potential for bias if the
assumptions underlying the extrapolations are wrong. Although
some research funded by the EuroQol Research Foundation in this
area is still ongoing, preliminary results show that DCE duration
estimates are sensitive to model specification and in particular to
assumptions made regarding duration preferences.36,37 Models
applied to cTTO commonly assume that the same proportional
trade-offs would bemade regardless of whether the remaining life
expectancy is long or short (<2 years), which may not hold.38,39
Nevertheless, violations of this assumption can be a bigger prob-
lem for DCE duration than for cTTO, because of the required
extrapolation. The consequences of these findings need to be
considered.
Conclusions
The lessons learned from EQ-5D-5L valuation have resulted in a
detailed valuation protocol, paired with a quality assurance pro-
cess and novel analytical approaches. The updated protocol has
enabled teams from all over the world to establish EQ-5D-5L value
sets.
The collective efforts that led to the refinement of the protocol
demonstrate that the EuroQol Group is dedicated to learn about
valuation and willing to revise protocol elements to improve the
validity and reliability of the results. Although TTO has been a
preferredmethod for health state valuation for 2 decades, we have
obtained important new insights concerning how respondent
behavior and features of the task work together to define the level
of precision of cTTO responses. These insights have emphasized
the importance of the interviewer’s role in motivating re-
spondents to give accurate responses and reacting to certain
respondent behaviors. We came to realize that demands placed
on the interviewer are high, making it unlikely that any inter-
viewer training, script, or software for performing interviews will
be sufficient to guarantee proper interviewer performance. This
motivated the introduction of a QC process and of new modeling
approaches.
Reflecting the nature of the most scientific endeavor,
improvement of valuation methods is a gradual process, and
value sets derived from procedures that were state-of-the-art at
the time could have benefited from later developments. It is likely
that 3-level value sets suffer from several of the issues described
here, and that the most recent 5-level valuation studies are im-
provements over the older 5-level value sets. Similarly, strategies
used to produce value sets for other questionnaires such as the
6-dimensional health state short form or the Health Utilities Index
have been subject to modification in the light of new empirical
results.40e43 It follows that value sets should not be considered as
permanent entities, but should have an expected life cycle with
anticipated updates or replacements that reflect gradual changes
in society, health preferences, and improved methods. How often
value sets should be updated is a question without any definite
answer.
Given the changes in perception about what works in valua-
tion, it is appropriate to recognize that the rigorous approach to
EQ-5D-5L valuation studies inspires trust. Yet we can also note
that the kind of insights that guide our current valuation work did
not exist when the EQ-5D-3L was originally valued. It is wise to
remain modest with respect to claims concerning the qualities of
older value sets, until we have returned to them and scrutinized
the methods used in constructing these value sets. Such research
is warranted to provide users and stakeholders with recommen-
dations regarding the use of the instruments in analysis and
healthcare decision making.
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